According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 2,14ย โฌ. In 2025 the company made an earnings per share (EPS) of 1,94ย โฌ an increase over its 2024 EPS that were of 0,04471ย โฌ.